Cue Biopharma (CUE) Other Non-Current Liabilities (2018 - 2021)

Cue Biopharma has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $89000.0 for Q2 2021.

• Other Non-Current Liabilities for Q2 2021 came in at $89000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $89000.0 (changed N/A YoY), and the FY2020 annual result was $1.9 million, down 51.78% from the prior year.
• Other Non-Current Liabilities came in at $89000.0 for Q2 2021 at Cue Biopharma, down from $1.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $6.4 million in Q2 2019 to a low of $89000.0 in Q2 2021.
• The 4-year median for Other Non-Current Liabilities is $2.5 million (2020), against an average of $2.9 million.
• Across the five-year window, Other Non-Current Liabilities surged 774.37% in 2019 and plunged 76.78% in 2020, its largest moves.
• Cue Biopharma's Other Non-Current Liabilities stood at $5.2 million in 2018, then dropped by 22.36% to $4.0 million in 2019, then plunged by 51.78% to $1.9 million in 2020, then plunged by 95.41% to $89000.0 in 2021.
• The last three Other Non-Current Liabilities figures came in at $89000.0 (Q2 2021), $1.3 million (Q1 2021), and $1.9 million (Q4 2020), per Business Quant data.